Main > NEUROLOGY. > Multiple Sclerosis > Treatment > AlemtuzuMAb (Anti CD52 MAb) > Co.: USA. G. (Phase III/Patent) > Web-Site (PR>2011. 04.14.2011)

---

This data is not available for free


Web-Site (PR>2011. 04.14.2011)'s products
This section has no products